Trifluridine-tipiracil + bevacizumab in the treatment of metastatic colorectal cancer - from the SUNLIGHT trial to routine clinical practice
Clem tohoto sdlen je poskytnout pehled dat s ohledem na kombinaci trifluridin-tipiracil + bevacizumab v rmci 3. linie lby metastatickho onemocnn. Jsou prezentovny hlavn vsledky registran studie SUNLIGHT, aktuln metaanalzy a podskupinov analzy studie SUNLIGHT. Souasn jsou diskutovna i data z reln klinick praxe, vetn vsledk vlastnho souboru pacient lench touto kombinac.
Authors
- Marián Liberko (ORCID: https://orcid.org/0000-0001-8338-1555)
- Renata Soumarová
Publication Details
- Journal
- Onkologie
- Published
- 2025-10-08
- DOI
- https://doi.org/10.36290/xon.2025.039
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00